RecruitingNCT02361554
This study is looking at whether a digital support tool can help people with Treatment-resistant Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 22 Years to 65 Years
- Countries
- United States
- Sponsor
- Johns Hopkins University
- Condition
- Schizophrenia
RecruitingNCT05527210
This study is looking at care and outcomes for people with Schizophrenia or schizoaffective disorder. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
RecruitingNCT06887192
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Canada, United States
- Sponsor
- MapLight Therapeutics
- Condition
- Schizophrenia
RecruitingNCT07379827
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Bristol-Myers Squibb
- Condition
- Schizophrenia
Not Yet RecruitingNCT07455084
This study is looking at whether 14C-SEP-380135 can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
RecruitingNCT06963034
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Neurocrine Biosciences
- Condition
- Schizophrenia
RecruitingNCT07010614
This study is looking at whether Intracranial electrodes can help people with Schizophrenia Disorders, Mental Disorder, or psychosis. Participants take part in Intracranial electrodes and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Stanford University
- Condition
- Schizophrenia
RecruitingNCT07434479
This study is looking at whether an online mindfulness program can help people with Schizophrenia Disorder, Schizoaffecitve Disorder, or Aggression. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Manhattan Psychiatric Center
- Condition
- Schizophrenia
RecruitingNCT04368039
This study is looking at whether Normobaric Oxygen can help people with Psychosis, Schizophrenia, or First-episode Psychosis. Participants take part in Normobaric Oxygen and complete follow-up assessments.
SchizophreniaOtherFrom 15 Years to 35 Years
- Countries
- United States
- Sponsor
- Nicholas Breitborde
- Condition
- Schizophrenia
Enrolling By InvitationNCT03970005
This study is looking at evaluate the long-term outcomes among individuals participating in this clinical service for people with Prodromal Schizophrenia. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 12 Years to 25 Years
- Countries
- United States
- Sponsor
- Ohio State University
- Condition
- Schizophrenia
RecruitingNCT07196462
This study is comparing 3 Minute iTBS to the L DLPFC with Precision Brain Stimulation for Cannabis Users with Healthy Controls for people with Cannabis Use, Schizophrenia, Psychosis, or Rtms. Participants receive 3 Minute iTBS to the L DLPFC or Precision Brain Stimulation for Cannabis Users with Healthy Controls and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Vanderbilt University Medical Center
- Condition
- Schizophrenia
RecruitingNCT06865937
This study is looking at whether Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE) can help people with Schizophenia Disorder or schizoaffective disorder. Participants take part in Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE) and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
RecruitingNCT07288567
This study is looking at evaluate the efficacy and safety of KarXT for treatment of Schizophrenia in adolescents. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 13 Years to 17 Years
- Countries
- Argentina, Colombia, Japan, Romania, United States
- Sponsor
- Bristol-Myers Squibb
- Condition
- Schizophrenia
RecruitingNCT06641297
This study is looking at care and outcomes for people with Schizophrenia Disorders. Taking part may give some people access to Music video game, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 15 Years to 45 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
Not Yet RecruitingNCT07423546
This study is looking at whether Xanomeline and trospium chloride (KarXT) can help people with SCHIZOPHRENIA 1 or Schizoaffecitve Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Schizophrenia
RecruitingNCT07419321
This study is looking at be the first to comprehensively examine the health impact of social isolation in SZ for people with Schizophrenia and Related Disorders. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 40 Years to 70 Years
- Countries
- Netherlands, Spain, United Kingdom, United States
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Condition
- Schizophrenia
Active Not RecruitingNCT04646200
This study is looking at whether cognitive behavioural therapy can help people with Insomnia or Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Schizophrenia
Not Yet RecruitingNCT07417904
This study is looking at whether cognitive behavioural therapy can help people with Violence Risk or Early Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 30 Years
- Countries
- United States
- Sponsor
- Howard University
- Condition
- Schizophrenia
RecruitingNCT06894212
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Japan, United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
RecruitingNCT07231497
This study is looking at whether a digital support tool can help people with Cognition or Healthy Participants. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
Not Yet RecruitingNCT07006935
This observational study is following people with Schizophrenia, Schizo Affective Disorder, or Schizophreniform Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Case Western Reserve University
- Condition
- Schizophrenia
Active Not RecruitingNCT05558332
This study is looking at adapt the current Youth-Nominated Support Team (YST) manual used to treat suicide risk for people at clinical high risk for psychosis for people with Psychosis, Suicide, Health Care Utilization, or Family Members. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 12 Years to 25 Years
- Countries
- United States
- Sponsor
- University of California, Irvine
- Condition
- Schizophrenia
RecruitingNCT07217652
This study is looking at examine how the human thalamus supports flexible thinking and behavior for people with Schizophrenia or Attention Deficit Disorder With Hyperactivity. Some participants may receive Within subject manipulation of working memory, cognitive control, and decision making instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- United States
- Sponsor
- Kai Hwang
- Condition
- Schizophrenia
RecruitingNCT06155682
This study is comparing repetitive transcranial magnetic stimulation (active) with sham rTMS for people with Schizophrenia. Participants receive repetitive transcranial magnetic stimulation (active) or sham rTMS and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
Active Not RecruitingNCT05857137
This study is looking at care and outcomes for people with Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Schizophrenia